Kinome-Wide Screening Identifies FAK as a Novel Post-Translational Regulator of PD-L1 Stability and Immune Evasion in Triple-Negative Breast Cancer
Open Access
- 17 October 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (20) , 10108
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by limited treatment options and poor prognosis. Although immune checkpoint inhibitors targeting the PD-1/PD-L1 axis have shown clinical promise, many TNBC patients exhibit resistance or limited response, underscoring the need to understand regulatory mechanisms of PD-L1 expression. Here, we performed a kinome-wide inhibitor screen using a HEK293A cell line stably expressing a NanoLuc-tagged PD-L1 construct lacking its endogenous promoter, to identify post-translational regulators of PD-L1 stability. We identified focal adhesion kinase (FAK) as a novel modulator of PD-L1. FAK inhibition significantly decreased PD-L1 levels in HEK293A cells but paradoxically increased PD-L1 expression in TNBC cell lines. Mechanistically, FAK directly interacts with PD-L1 to modulate its stability independently of its kinase activity. Functionally, FAK inhibition enhanced membrane PD-L1 expression and reduced T-cell-mediated cancer cell killing, suggesting increased immune evasion. These findings reveal a novel role for FAK in immune modulation and suggest that combining FAK inhibitors with PD-L1 blockade may offer a promising strategy for TNBC treatment.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (186142, 148629)
This publication has 35 references indexed in Scilit:
- Rho‐associated protein kinase‐dependent moesin phosphorylation is required for PD‐L1 stabilization in breast cancerMolecular Oncology, 2020
- PD‐1/PD‐L1 pathway: Basic biology and role in cancer immunotherapyJournal of Cellular Physiology, 2019
- PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activationInternational Journal of Cancer, 2017
- Elements of cancer immunity and the cancer–immune set pointNature, 2017
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityNature Communications, 2016
- PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinomaMedical Oncology, 2015
- FAK in cancer: mechanistic findings and clinical applicationsNature Reviews Cancer, 2014
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasisCancer Letters, 2010